Table 4.
Variable | Relative riska | 95% CIc | P-value |
---|---|---|---|
Initial UF Treatmentb | |||
Evidence of type I or II BVDV — Yes vs. No | 0.30 | 0.04–2.23 | 0.240 |
Evidence of type I BVDV — Yes vs. No | N/A | N/A | N/A |
Evidence of type II BVDV — Yes vs. No | 0.57 | 0.08–4.04 | 0.570 |
Initial NF Treatmentb | |||
Evidence of type I or II BVDV — Yes vs. No | 1.34 | 0.49–3.64 | 0.568 |
Evidence of type I BVDV — Yes vs. No | 2.77 | 1.02–7.51 | 0.046 |
Evidence of type II BVDV — Yes vs. No | N/A | N/A | N/A |
Overall Mortality | |||
Evidence of type I or II BVDV — Yes vs. No | 5.00 | 1.82–13.71 | 0.002 |
Evidence of type I BVDV — Yes vs. No | 4.38 | 1.52–12.65 | 0.006 |
Evidence of type II BVDV — Yes vs. No | 2.76 | 0.6–12.64 | 0.192 |
Infectious Mortality | |||
Evidence of type I or II BVDV — Yes vs. No | 6.03 | 1.81–20.06 | 0.003 |
Evidence of type I BVDV — Yes vs. No | 3.83 | 0.91–16.10 | 0.067 |
Evidence of type II BVDV — Yes vs. No | 4.37 | 0.96–19.95 | 0.057 |
Relative risk — the ratio of the rate of disease in non-persistently infected animals with evidence of type-specific BVDV infection on arrival divided by the rate of disease in animals with no evidence of type-specific BVDV viraemia on arrival
UF — undifferentiated fever and NF is no fever
95% CI — the 95% confidence interval calculated for each relative risk, corrected for feedlot effects and intra-pen clustering of animal health events using generalized linear modeling techniques. The partially maximized likelihood function was used to calculate the confidence intervals. When convergence of the confidence interval could not be attained using the maximized likelihood function, asymptotic normality was used to calculate the confidence intervals. Values for unstable statistical models that would not solve are recorded as N/A